Olorofim
F901318/0041
Phase 3 small_molecule active
Quick answer
Olorofim for Invasive Aspergillosis is a Phase 3 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Invasive Aspergillosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active